| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 320.524 | 353.365 | 352.670 | 432.155 | 421.323 | 401.036 | 376.468 | 489.063 | 415.936 | 487.450 |
| Total Income - EUR | 321.249 | 354.626 | 353.171 | 432.353 | 422.258 | 402.248 | 376.845 | 489.368 | 517.078 | 489.760 |
| Total Expenses - EUR | 291.237 | 358.444 | 366.140 | 464.138 | 404.834 | 452.206 | 441.432 | 392.289 | 470.860 | 415.680 |
| Gross Profit/Loss - EUR | 30.012 | -3.818 | -12.969 | -31.784 | 17.423 | -49.959 | -64.588 | 97.079 | 46.218 | 74.080 |
| Net Profit/Loss - EUR | 30.012 | -3.818 | -16.276 | -36.124 | 13.190 | -53.984 | -68.357 | 92.184 | 42.038 | 65.619 |
| Employees | 11 | 11 | 11 | 9 | 10 | 10 | 9 | 8 | 5 | 5 |
Check the financial reports for the company - Homeofarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.417 | 3.331 | 3.362 | 2.691 | 3.127 | 3.974 | 4.977 | 3.962 | 1.137 | 2.023 |
| Current Assets | 130.368 | 131.202 | 187.014 | 239.209 | 245.461 | 203.469 | 160.010 | 266.747 | 206.435 | 228.863 |
| Inventories | 85.865 | 88.663 | 135.798 | 160.803 | 212.167 | 188.248 | 138.456 | 217.898 | 124.369 | 137.955 |
| Receivables | 28.543 | 27.137 | 36.464 | 74.681 | 38.562 | 36.169 | 29.521 | 46.610 | 36.067 | 35.870 |
| Cash | 15.960 | 15.402 | 14.753 | 3.725 | -5.267 | -20.947 | -7.967 | 2.240 | 46.000 | 55.038 |
| Shareholders Funds | -104.570 | -107.321 | -121.781 | -155.670 | -139.465 | -190.805 | -254.930 | -163.537 | -121.004 | -54.708 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 245.805 | 249.144 | 317.242 | 397.590 | 388.142 | 399.594 | 420.600 | 434.749 | 328.895 | 285.782 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Homeofarm S.r.l.